American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Business

Teladoc rises on increased demand, should you buy this high risk play?

by admin September 18, 2024
September 18, 2024
Teladoc rises on increased demand, should you buy this high risk play?

Teladoc Health stock is setting up for a good short-term trading opportunity after Jefferies analysts noticed the possibility of a short-term surge due to increased demand.

The brokerage house has boosted its price target on the stock from $8 to $10.

The short-term optimism comes from the analysis of the web traffic to the company’s mental health business website, BetterHelp.

The web traffic was consistently declining for the last 12 months. However, July and August traffic has shown an increase in demand for the company’s mental health services.

Analysts are already estimating an 11% decline in revenues for the BetterHelp division in the third quarter.

Overall, they expect a 5% drop in revenue. The web traffic data has prompted them to reevaluate their expectations of the company’s earnings.

Combining the above information with the fact that Teladoc has a 16% short interest, there is room for a short-term rally in the stock.

As interest rates start going down, beaten-down stocks could produce a rally simply because of the availability of cheaper money.

New management is driving optimism

On the 10th of June, Teladoc appointed Charles Divita as its new CEO. This would usually be considered good news. But it didn’t stop the stock from continuing to slide.

The new CEO withdrew guidance for the fiscal year 2024 and also dropped the 3-year outlook. This would usually be considered a high risk move. Some would even call it a sign of bad management.

However, for a stock that was down over 95% from its all-time highs, it wasn’t a big deal.

Three months on, one can observe a noticeable change in trend. This stock is recovering.

And the web traffic data is pointing to an increase in people using Teladoc’s services. Whatever the new CEO did in the three months he has been in charge seems to be working.

A manageable debt situation

The company has $1.6 billion in convertible notes outstanding. Half of these mature in 2025.

Its cash position of $1.16 billion would help it cover the $800 million due next year. A health-positive free cash flow should cater to the rest of the payment too.

Shareholders should be alert for one thing though. Convertible notes can also be converted into equity. If that happens, existing shareholders will get diluted.

To conclude, Teladoc’s healthy cash position, positive cash flow, and determined management should help it finally recover from a horrible stock slump.

The short interest and a changing trend should be good enough reasons for traders to drive the stock price up.

An entry at this point could be a safe bet because of the short-term triggers. If they materialize, holding the stock for the long term will become easier, though the journey will be volatile.

The post Teladoc rises on increased demand, should you buy this high risk play? appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Is it safe to buy gold, GLD, and IAU ETFs ahead of FOMC rate cut?
next post
The Children’s Place stock has short squeezed; time to buy?

Related Posts

Ireland set to invest Apple’s €14bn tax windfall...

October 2, 2024

Can Palantir challenge big tech’s dominance?

October 9, 2024

Crypto today: FARTCOIN and iDEGEN steal the show...

December 25, 2024

Boeing taps aerospace veteran Kelly Ortberg to replace...

August 1, 2024

Long NEO: NeoGenomics Reverses Sharply Post-Earnings, Failed Range...

February 20, 2025

SYLD just soared to a record high: is...

October 17, 2024

BNB price prediction: Binance daily trading volume jumps...

January 17, 2025

HSBC’s first female CFO in 160 years: who...

October 22, 2024

Global automakers cut forecasts as Trump tariffs and...

April 30, 2025

US picks Palantir as data analysis partner, but...

May 31, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • GMS stock jumps 29% on takeover interest from Home Depot, QXO, analysts raise PTs

      June 22, 2025
    • Japan’s rice price surge: what’s driving it and why it could spark a political crisis

      June 22, 2025
    • BofA raises STOXX 600 target amid resilient global growth, warns on Mideast risks

      June 22, 2025
    • Palantir co-founder: US must prevent Iranian nukes

      June 22, 2025
    • Fed governor Waller advocates for July rate cut amid tariff, labor market outlook

      June 21, 2025

    Categories

    • Business (3,199)
    • Investing (2,531)
    • Latest News (2,000)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved